CNA Financial Corporation (CNA) Stock Price & Analysis
CNA Financial Corporation (CNA) closed at USD 49.39 on Thursday, October 22, 2026, up 2.21% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 48.32; the Oct 22, 2026 session ranged USD 48.48–49.48 on volume of 271,823 shares. Market capitalization is $13.36B, with a 52-week range of USD 41.53–55.71 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:47 UTC.
Also available as compact Markdown for AI agents: nexqual.com/CNA.md
Key facts (CNA)
- Last four reported quarters (through Jun 30, 2026): revenue $15.2B, net income $1.24B (8.2% margin), free cash flow $2.25B (SEC filings).
- Valuation: P/E 10.8x (avg 11.2x at the last 3 fiscal year-ends), net debt $2.63B.
- 1 of 80 tracked superinvestors hold CNA (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 2 Form 4 filings, $1.6M; 2 not under a Rule 10b5-1 plan ($1.6M); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Strong Sell (mean 5.00 on a 1–5 scale) (1 analysts), mean target USD 45 (range 45–45).
- Total return with dividends: 1Y +18.0% vs S&P 500 +14.9%; 5Y +58.5% vs S&P 500 +80.3%.
- Next earnings: 2026-11-02, EPS estimate USD 1.13, revenue estimate $0K.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (CNA)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $11.9B | $11.9B | $13.3B | $14.3B | $15.0B | $15.2B |
| Net income | $1.18B | $682M | $1.21B | $959M | $1.28B | $1.24B |
| EPS (diluted) | $4.34 | $2.51 | $4.43 | $3.52 | $4.69 | — |
| Free cash flow | $1.97B | $2.45B | $2.19B | $2.48B | $2.40B | $2.25B |
| Net margin | 9.9% | 5.7% | 9.1% | 6.7% | 8.5% | 8.2% |
| Revenue growth | +10.2% | -0.2% | +12.0% | +7.3% | +5.0% | — |
| Cash + short-term investments | — | $475M | $345M | $472M | $425M | — |
| Total debt | $2.78B | $2.78B | $3.03B | $2.97B | $2.97B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (CNA)
P/E 10.8x · P/S 0.9x · EV/Sales 1.1x · P/FCF 5.9x · P/B 1.2x · FCF yield 16.87% · Earnings yield 9.26% · Dividend yield (paid, TTM) 7.94% · Buyback yield (TTM) 0.27% · Net debt $2.63B · EV $16.0B
P/E at fiscal year-ends: Dec 2025 10.2x, Dec 2024 13.8x, Dec 2023 9.6x.
Superinvestors (SEC 13F-HR, Q2 2026) (CNA)
1 of 80 tracked investors hold CNA. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Torray Funds | 3.42% | $25.4M | Added +11.0% |
Insider sales (SEC Form 4, open-market, last ~7 months) (CNA)
0 of 2 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-08-04 | James Mark Steven | EVP, Chief Risk & Rein Off | 8,273 | $440K | 23.8% | No | Too little history (no open-market trades in 2023) |
| 2026-08-04 | Franzetti Daniel Paul | EVP & CAO | 22,656 | $1.2M | 25% | No | Too little history (no open-market trades in 2023) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (CNA)
Consensus Strong Sell (mean 5.00 on a 1–5 scale), 1 analysts; mean target USD 45 (low 45, high 45).
Total return (dividends reinvested) (CNA)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +18.0% | +58.5% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +18.0% | +9.6% |
| Volatility (annualized) | 20.8% | 20.7% |
| Max drawdown | -18.1% (Jul 2026→Sep 2026) | -24.0% (Mar 2022→Sep 2022) |
CNA revenue by business segment (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Specialty | $367.0M | 100.0% | -7.8% |
| Total revenue | $367.0M | 100% | — |
CNA revenue by product line (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Managementand Professional Liability | $802.0M | 218.5% | +3.1% |
| Other Commercial Insurance | $517.0M | 140.9% | +8.8% |
| Construction | $512.0M | 139.5% | -0.4% |
| Middle Markets | $509.0M | 138.7% | +8.8% |
| Warranty Alternative Risks | $406.0M | 110.6% | -9.0% |
| Surety | $208.0M | 56.7% | +1.5% |
| CNA Europe | $166.0M | 45.2% | +6.4% |
| Small Business | $157.0M | 42.8% | -2.5% |
| CNA Canada | $114.0M | 31.1% | +9.6% |
| Hardy | $101.0M | 27.5% | -1.0% |
| Total revenue | $367.0M | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
CNA suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | LOEWS CORP (L) | “We have also entered into services agreements and a registration rights agreement with Loews, and we may in the future enter into other agreements with Loews.” |
Quoted from the company's 10-K filed Feb 10, 2026.
Companies that name CNA in their SEC reports
| Relationship to CNA | Company | Filing | Sentence |
|---|---|---|---|
| supplier | LOEWS CORP (L) | 10-K Feb 10, 2026 | “CNA's products and services are primarily marketed through independent agents, retail and wholesale brokers and managing general underwriters to a wide variety of customers, including small, medium and large businesses, insurance companies, associations, professionals” |
CNA company outlook (results filed Aug 3, 2026)
- “These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and generally include words such as "believes," "expects," "intends," "anticipates," "estimates" and similar expressions.”
Quoted word-for-word from the SEC 8-K results press release.
CNA analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $1.13 | $1.14 | -0.9% | $0 | 1 |
| Next quarter (ends Dec 2026) | $1.06 | $1.07 | -0.9% | $0 | 1 |
| Current fiscal year (ends Dec 2026) | $4.20 | $4.05 | +3.7% | $0 | 1 |
| Next fiscal year (ends Dec 2027) | $4.80 | $4.80 | +0.0% | $0 | 1 |
Key Statistics (as of October 23, 2026 at 09:47 UTC)
| Price | USD 49.39 |
|---|---|
| Change | ▲ 2.21% (up) |
| Previous Close | USD 48.32 |
| Open | USD 48.49 |
| Day Range | USD 48.48 – 49.48 |
| 52-Week Range | USD 41.53 – 55.71 |
| Volume | 271,823 shares |
| Market Cap | $13.36B |
| Exchange | NYQ |
Technical Analysis (CNA)
Nexqual's technical model rates CNA "BUY" based on 5 bullish and 2 bearish signals across 127 daily candles, as of October 23, 2026 at 09:47 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 67.03 (neutral) |
| vs SMA50 | Above (USD 47.91) |
| MACD | 0.22 (positive) |
Analyst Ratings (CNA)
Wall Street analysts rate CNA "Strong Sell" based on 1 analysts, with a mean price target of USD 45 (range USD 45–45), per Nexqual as of October 23, 2026 at 09:47 UTC.
| Consensus Rating | Strong Sell |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 45 |
| High Target | USD 45 |
| Low Target | USD 45 |
| Buy / Hold / Sell | 0 / 0 / 1 |
Earnings (CNA)
| Next Earnings Date | 2026-11-02 |
|---|---|
| EPS Estimate | USD 1.13 |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 1.19 vs est 1.05 ▲ beat |
| 2026-03-31 | USD 0.83 vs est 1.24 ▼ miss |
| 2025-12-31 | USD 1.16 vs est 1.34 ▼ miss |
| 2025-09-30 | USD 1.5 vs est 1.32 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:47 UTC.
Financials & Fundamentals (CNA)
| Total Revenue | $15.15B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +3.00% |
| Gross Margin | +31.09% |
| Operating Margin | +11.44% |
| Profit Margin | +8.16% |
| ROE | +11.32% |
| Debt / Equity | 0.27 |
| Current Ratio | 0.37 |
| Total Cash | $2.06B |
| Total Debt | $2.97B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $2.25B (14.9% of revenue) |
Source: Nexqual, October 23, 2026 at 09:47 UTC.
Financial Health Score (CNA)
Nexqual rates CNA Financial Corporation's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:47 UTC.
| Growth | Critical — Revenue -100% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Solid — $339M cash and investments vs $2.97B debt (Jun 2026, SEC) |
| Cash Flow | Solid — FCF $2.25B (last 4 quarters to Jun 2026, SEC), 15% margin |
| Efficiency | Mixed — ROE 11%, ROA 1.5% |
Ownership (CNA)
| Insider Ownership | +0.46% |
|---|---|
| Institutional Ownership | +101.01% |
| Shares Outstanding | 270.60M |
| Float | 20.58M |
| Short % of Float | +17.68% |
Source: Nexqual, October 23, 2026 at 09:47 UTC.
Leadership (CNA)
CNA Financial Corporation is led by Douglas Merle Worman B.A., President, CEO & Chairman, per Nexqual as of October 23, 2026 at 09:47 UTC.
| President, CEO & Chairman | Douglas Merle Worman B.A. |
|---|---|
| Executive VP & CFO | Scott Robert Lindquist |
| Senior Vice President of Investments & Treasury | Amy Caroline Adams B.B.A. |
| Vice President of Investor Relations & Rating Agencies | Ralitza Todorova C.F.A. |
| Senior Vice President & General Counsel | Jeffrey John Neuenschwander |
Major Backers & Investors (CNA)
Notable institutional backers of CNA Financial Corporation include AQR Capital Management, LLC, First Trust Advisors LP, Morgan Stanley, according to Nexqual as of October 23, 2026 at 09:47 UTC.
Active Investors
| Investor | Stake |
|---|---|
| AQR Capital Management, LLC | 1.04% |
| First Trust Advisors LP | 0.39% |
| Morgan Stanley | 0.36% |
| First TRT Exch-Trd Fd.-First TRT Value Line Dividend Index Fd. | 0.36% |
| Quantinno Capital Management, LP | 0.32% |
| River Road Asset Management, LLC | 0.3% |
| Charles Schwab Investment Management, Inc. | 0.3% |
| Two Sigma Investments, LP | 0.3% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 0.61% |
Source: Nexqual, October 23, 2026 at 09:47 UTC.
Legal & Regulatory Risks from CNA Financial Corporation's Latest 10-K (filed 2026-02-10)
- We have exposures related to asbestos and environmental pollution (A&EP) claims, which could result in material losses.
- Any significant breach in our data security infrastructure or our vendors' facilities or systems could disrupt business, cause financial losses and damage our reputation, and insurance coverage may not be available for claims related to a breach.
- We are subject to capital adequacy requirements and, if we are unable to maintain or raise sufficient capital to meet these requirements, regulatory agencies may restrict or prohibit us from operating our business.
- We are subject to extensive existing state, local, federal and foreign governmental regulations that restrict our ability to do business and generate revenues; additional regulation or significant modification to existing regulations or failure to comply with regulatory requirements may have a materially adverse effect on our business, results of operations and financial condition.
Source: SEC EDGAR 10-K, Item 1A, official filing.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AFG | American Financial Group, Inc. | USD 153.46 | ▲ 2.53% |
| AIZ | Assurant, Inc. | USD 288.85 | ▲ 1.6% |
| ORI | Old Republic International Corp | USD 40.08 | ▼ 0.12% |
| KNSL | Kinsale Capital Group, Inc. | USD 390.64 | ▲ 3.7% |
| THG | Hanover Insurance Group Inc | USD 239.59 | ▲ 3.3% |
| L | Loews Corporation | USD 113.68 | ▲ 1.75% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:47 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt